AHMF
RACP Guidelines for CFS

Latest News

About Us


Research

Information

Advocacy

Conference

Guidelines

Media

Links

In 1996 Dr Michael Wooldridge, Minister for Health and Family Services, approved an application to Medicare to provide funding of $130,000 to the Royal Australasian College of Physicians (RACP) "to produce a series of guidelines on the most clinically relevant and cost effective methods of diagnosing and treating chronic fatigue syndrome".
First draft released December, 1997.
Second draft released June, 2001.

Critical responses to draft 2, June 2001

Peter C. Rowe Professor of Pediatrics, John Hopkins Hospital, Baltimore USA
Abhijit Chaudhuri Clinical Lecturer in Neurology, University of Glasgow
Peter Del Fante GP, Public Health Physician
Ellie Stein Psychiatrist
Archive Further responses

Foundation correspondence regarding Guidelines

Essential reading for a critical overview of Guidelines development

Address to Federal Government Policy Committee of Health and Aging Christine Hunter
December 2002
CFS clinical practice guidelines Simon Molesworth, Richard Larkins, to the MJA
Response Richard Larkins, President, RACP Working Group
First do no harm AHMF correspondence to Richard Larkins, President, RACP Working Group 19/4/2002
Appendix 1 - Failures of Process AHMF examines the guidelines development 1996-2002
Semantics-Based Medicine for CFS?

AHMF correspondence to RACP Working Group
4/8/2000

Betrayal of the Severely Ill?

AHMF response to RACP Draft Guidelines, extensive references, letters of support from consumer groups
22/4/1998

RACP Guidelines Development: Chronology

1999 Sydney ME/CFS Conference Consumer Address Ted Shaw—critical analysis of RACP Draft Guidelines and their effect on the community
1998 Sydney ME/CFS Conference Consumer Address Ted Shaw—critical analysis of RACP Draft Guidelines
Relevant correspondence: Professor D. Wakefield 11/4/1997

The AHMF's Submission to Draft 1

The full text of the AHMF's submission to the RACP CFS Working Group
1997


Latest News | Research | Information | Advocacy | Conference | Guidelines

Phone: +61 2 4861 3244